Hiroyuki Misawa

Hiroyuki Misawa

Signal active

Managing Director

Bio

Dr. Misawa is currently one of the directors of investment group in Japan Asia Investment Co., Ltd. (JAIC). With over 10 years' experience in healthcare investment, he leads biotech, medical device and medical service investments in JAIC and is a member of investment committee of a fund of funds in JAIC which invest to top tier Life Science VCs in Europe.

He also plays a major role as investment committee member of some JAIC's investment funds in China. Prior to join JAIC group, Dr. Misawa held academic position as an assistant professor at Kurume University and University of Shizuoka, and a visiting research fellow at Baylor College of Medicine for 7 years. He received his BS, MS and PhD degrees in Biochemistry from Saitama University.

Location

Tokyo, Tokyo, Japan, Asia

Social

Primary Organization

Japan Asia Investment

Japan Asia Investment

Founded

1981

Investment

65

Lead investment

12

Exits

20

Employees

11-50

Industry

Financial Services, Venture Capital, Web Hosting, Business Development

Jobs history

3

ARTham Therapeutics

Director

Invalid date - Current

Integral Geometry Science

Auditor

Invalid date - Current

iHeart Japan

Director

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Hiroyuki Misawa is the Managing Director at Japan Asia Investment, based in Asia. With a background in Financial Services, Hiroyuki Misawa has a rich history of leadership and innovation. Hiroyuki Misawa studied BS unknown @ Saitama University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

6

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
May 10, 2017
REGiMMUNE REGiMMUNE
Series E - REGiMMUNE
REGiMMUNE Japan Asia Investment
5.7M
Jul 10, 2018
ARTham Therapeutics ARTham Therapeutics
Series A - ARTham Therapeutics
ARTham Therapeutics Miyako Capital
0
Mar 15, 2021
VLP Therapeutics VLP Therapeutics
Series A - VLP Therapeutics
VLP Therapeutics Miyako Capital
16.0M
Dec 27, 2021
VLP Therapeutics VLP Therapeutics
Series A - VLP Therapeutics
VLP Therapeutics Miyako Capital
21.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.